Shandong Weigao Blood Purification Products Co., Ltd. (SHA:603014)
China flag China · Delayed Price · Currency is CNY
35.21
-0.44 (-1.23%)
May 14, 2026, 4:00 PM EDT

SHA:603014 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,3201,584818.09649.62595.98330.38
Trading Asset Securities
1,4621,221330.1370.11-2.29
Cash & Short-Term Investments
2,7822,8051,148719.73595.98332.66
Cash Growth
137.28%144.29%59.54%20.77%79.15%-
Accounts Receivable
931.3925.58934.83929.831,098919.83
Other Receivables
14.2914.4117.267.233.3770.36
Receivables
945.59939.99952.1937.071,101990.19
Inventory
815.12823.25757.07900.14661.07561.22
Other Current Assets
124.49105.48119.1995.6681.5698.66
Total Current Assets
4,6674,6742,9772,6532,4401,983
Property, Plant & Equipment
3,2813,2983,3843,3303,3543,219
Long-Term Investments
187.03177.99142.86170.8126.74104.55
Other Intangible Assets
287.9290.07295.66302.79297.79305.92
Long-Term Accounts Receivable
--0.150.290.46-
Long-Term Deferred Tax Assets
68.6666.4462.5562.8868.954.59
Long-Term Deferred Charges
10.748.477.7611.4815.9921.36
Other Long-Term Assets
93.193.79120.16151.16105.98251.97
Total Assets
8,5968,6086,9906,6826,4105,940
Accounts Payable
505.36570.4418.9649710.74526.01
Accrued Expenses
125.12204.72193.66207.68226.15138.4
Short-Term Debt
--3.186.6441.84679.18
Current Portion of Long-Term Debt
6.02----121.18
Current Portion of Leases
-2.95.482.871.920.32
Current Income Taxes Payable
39.669.1336.1918.0310.0819.6
Current Unearned Revenue
248.33294.72295.38249.52293.07186.8
Other Current Liabilities
334.65333.52358.97320.72358.92482.47
Total Current Liabilities
1,2591,4151,3121,4541,6432,154
Long-Term Leases
10.870.032.651.041.83-
Long-Term Unearned Revenue
69.3571.5578.9789.9998.35109.88
Long-Term Deferred Tax Liabilities
2.872.81----
Total Liabilities
1,3421,4901,3931,5451,7432,264
Common Stock
417.75417.75370.25370.25370.25350
Additional Paid-In Capital
4,7754,7583,7003,6893,6623,007
Retained Earnings
2,0611,9431,5261,077634.89319.93
Comprehensive Income & Other
-0.06-0.31-0.17-0.31-0.17-0.36
Total Common Equity
7,2547,1195,5975,1364,6673,676
Minority Interest
0.010.01----
Shareholders' Equity
7,2547,1195,5975,1364,6673,676
Total Liabilities & Equity
8,5968,6086,9906,6826,4105,940
Total Debt
16.892.9311.310.5545.6800.68
Net Cash (Debt)
2,7652,8021,137709.18550.38-468.02
Net Cash Growth
137.62%146.47%60.32%28.85%--
Net Cash Per Share
6.797.093.061.921.51-1.33
Filing Date Shares Outstanding
422.52417.75370.25370.25363.84351.11
Total Common Shares Outstanding
422.52417.75370.25370.25363.84351.11
Working Capital
3,4083,2581,6651,198797.07-171.23
Book Value Per Share
17.1717.0415.1213.8712.8310.47
Tangible Book Value
6,9666,8295,3014,8344,3693,371
Tangible Book Value Per Share
16.4916.3514.3213.0512.019.60
Buildings
-2,3422,1752,1062,0801,528
Machinery
-2,2291,8831,7951,7691,714
Construction In Progress
-322.46768.12667.77549.49824.27
Source: S&P Global Market Intelligence. Standard template. Financial Sources.